Related Experiment Video
Updated: Oct 23, 2025
10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.5K
Reply to: "HbA1c and Motor Outcome in Parkinson's Disease in the Mark-PD Study"
Ioanna Markaki1,2, Theodora Ntetsika1,2, Per Svenningsson1,2,3
1Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Abstract
No abstract available in PubMed .
Related Concept Videos
01:24Parkinson's Disease: Treatment
562
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
562
01:15Parkinson's Disease: Overview
981
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
981